This site is intended for healthcare professionals only
LoginRegister
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantUSFDA issues 6 observations for Piramal Pharma Turbhe facility
Aurobindo Pharma arm gets European Commission authorization to market Dyrupeg in EUAurobindo Pharma arm Eugia Steriles gets 5 UFSDA observations
Merck to begin Phase 3 trials for investigational once monthly HIV prevention pillMerck Welireg receives European Commission nod for two indications
Revise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, MarketersRevise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, Marketers
USFDA issues EIR for Cohance Lifesciences Telangana facilityCDSCO, Drug Officials Intensify Inspections in TN Over Alleged Rabbit Blood Hair Oil Sales
Multiple Ayurvedic medicines seized in TelanganaMultiple Ayurvedic medicines seized in Telangana
Abbvie CEO Robert A Michael to assume additional role of Board ChairmanAbbvie CEO Robert A Michael to assume additional role of Board Chairman
Biocon, NCSM partnerBiocon Biologics Yesintek gets European Commission approval for plaque psoriasis, psoriatic...
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAUSFDA concludes inspection at Zydus Lifesciences Ahmedabad site with zero observations
Aurobindo Pharma arm gets marketing authorisation for Zefylti in EUAurobindo Pharma arm gets marketing authorisation for Zefylti in EU
Alembic Pharma appoints Jigr Shah as Head - Business FinanceAlembic Pharma gets USFDA EIR for Jarod facility
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study WaivedZydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in US
X